Search clinical trials for: FDA Approved Off-Label Chemotherapy

Total 14227 results

[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Radiolabeled Monoclonal Antibody and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With High-Risk Lymphoid Malignancies

Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Recurrent Mantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Refractory T-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent T-Cell Non-Hodgkin Lymphoma | Refractory Mantle Cell Lymphoma

United States
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
Washington University School of Medicine
AssureRx Health, Inc.

Terminated

Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder

Depressive Disorder | Depression | Major Depressive Disorder | Depression, Unipolar | Depressive Episode

United States
National Institutes of Health Clinical Center (CC)

Terminated

Comparing Magnetic Resonance Imaging/Spectroscopy Techniques

Tumors | Abdominal Organs - Lipodystrophy

United States
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
Baltimore VA Medical Center

Completed

Intermittent Pneumatic Compression of the Upper Extremity for Post-Operative VTE Prophylaxis

Venous Thromboses
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
ViiV Healthcare

Completed

New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects

HIV Infection | Infection, Human Immunodeficiency Virus I

United States, Spain, Germany, Canada, Belgium, Portugal, Italy, France, United Kingdom
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
NeuroWave Systems Inc.
Fraser Health; U.S. Army Medical Research Acquisition Activity

Completed

Effectiveness of the NeuroSENSE for Monitoring the Hypnotic Depth of Anesthesia

Depth of Anesthesia (DOA)

Canada
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Withdrawn

CAR.CD19-CD28-zeta-2A-iCasp9-IL15-Transduced Cord Blood NK Cells, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Participants With B-cell Lymphoma

Mantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | CD19 Positive

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma

Refractory Hodgkin Lymphoma | Recurrent Adult Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | T-Cell Chronic Lymphocytic Leukemia | Recurrent Childhood Non-Hodgkin... and other conditions

United States, Germany
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]
Alan D. Waxman, M.D.

Completed

FDG-PET/CT in the Evaluation of Patients With Suspected Cholecystitis

Cholecystitis

United States
University of Wisconsin, Madison

Completed

Asthma and Obstructive Sleep Apnea (OSA)

Asthma | Obstructive Sleep Apnea

United States
National Cancer Institute (NCI)

Terminated

Chemotherapy Followed by ESO-1 Lymphocytes and Aldesleukin to Treat Metastatic Cancer

Metastatic Cancer | Metastatic Melanoma | Metastatic Renal Cell Cancer

United States

3

Subscribe